We are still accepting applications for September 2020 start on our MSc in
Model-based Drug Development programme. Our MSc focuses on the modelling and
simulation skills that are currently transforming the drug development
industry. The course has been developed with an emphasis on mechanistic
approaches to assessing and predicting pharmacokinetics and pharmacodynamics
(PKPD), such as physiologically-based pharmacokinetics (PBPK). Full-time
students benefit from immersion in the varied biomedical research environment
at The University of Manchester, including interaction with research staff at
the renowned Centre for Applied Pharmacokinetic Research.
We require an UG honours degree (minimum Lower Second or equivalent) from a
reputable internationally-recognised institution. You will qualify as a
modeller with key skills in computational approaches in pharmacokinetics and
pharmacodynamics. Some of our modules include Introduction to Basic
Pharmacokinetics and Pharmacodynamics, In-vito-In-vivo extrapolation (IVIVE) in
ADME, Physiologically- based Pharmacokinetic Modelling, Advanced topics
(including modelling of absorption) in PBPK, Data Analysis in Pharmacokinetics
and Pharmacodynamics and Research project.
The aim of the course is to provide specialist knowledge and skills that are
highly relevant for a career linked to drug development and pharmaceutical
industry. On the course you will develop and acquire experience of using
different software platforms related to pharmacometric data analysis including
R, Phoenix, NONMEM, MATLAB, Simcyp, and MONOLIX. The course emphasises the
development of problem-solving skills. A large portion of the learning involves
structured problems requiring you to apply theory and practical skills to solve
typical problems that arise in drug development.
Our distance learning option is ideal for scientists linked to the
pharmaceutical industry who wish to expand their expertise while working in the
industry. It is also possible to take certain modules/units on the programme as
a standalone, CPD type course in 6weeks for 15 credit or 12weeks for 30credits
modules/units.
For more information please visit our website
https://www.manchester.ac.uk/study/masters/courses/list/08749/msc-model-based-drug-development/
Regards
Kay
Kayode Ogungbenro, PhD
Lecturer in Cancer Pharmacometrics | Division of Pharmacy and Optometry |
School of Health Sciences
The University of Manchester | Manchester M13 9PT | United Kingdom
Tel: +441612752399
Email:
[email protected]<mailto:[email protected]>
Web: https://www.research.manchester.ac.uk/portal/kayode.ogungbenro.html